e-learning
resources
Vienna 2003
Monday 29.09.2003
Immunology of interstitial lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Bronchoalveolar lavage fluid Interferon-gamma levels and natural killer activity in cryptogenic fibrosing alveolitis
T. P. Ses, A. S. Zaharova, L. N. Novikova, V. P. Molodzova, O. E. Baklanova (St Petersburg, Russia)
Source:
Annual Congress 2003 - Immunology of interstitial lung diseases
Session:
Immunology of interstitial lung diseases
Session type:
Poster Discussion
Number:
1511
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. P. Ses, A. S. Zaharova, L. N. Novikova, V. P. Molodzova, O. E. Baklanova (St Petersburg, Russia). Bronchoalveolar lavage fluid Interferon-gamma levels and natural killer activity in cryptogenic fibrosing alveolitis. Eur Respir J 2003; 22: Suppl. 45, 1511
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
The new challenge of CTD-ILD: from basic science to clinical setting
Related content which might interest you:
Concentrations of IL4Ra and TNFa in bronchoalveolar lavage fluid can distinguish hypersensitivity pneumonitis from other fibrosing interstitial lung diseases
Source: International Congress 2017 – Lung fibrosis: basic science
Year: 2017
Bronchoalveolar lavage (BAL) in the differential diagnosis of sarcoidosis, extrinsic allergic alveolitis and BOOP
Source: Eur Respir J 2003; 22: Suppl. 45, 255s
Year: 2003
Bronchoalveolar lavage and peripheral blood NK cells in idiopathic interstitial pneumonias
Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis
Year: 2009
Soluble Fas-ligand levels in bronchoalveolar lavage fluid before and after interferon-γ-1b treatment in idiopathic pulmonary fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 334s
Year: 2005
Bronchoalveolar lavage in idiopathic pulmonary fibrosis
Source: International Congress 2017 – IPF: from the bench to the bedside
Year: 2017
Immune alveolitis profile in bronchoalveolar lavage of infiltrative lung diseases: not just counting matters.
Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020
Bronchoalveolar lavage
Source: Eur Respir Mon; 2010: 48: 59–72
Year: 2010
Investigation of cellularity and the cytokines profile of bronchoalveolar lavage in sarcoidosis
Source: Eur Respir J 2003; 22: Suppl. 45, 255s
Year: 2003
The impact of smoking on bronchoalveolar lavage fluid (BALf) amyloid A concentration in patients with sarcoidosis
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013
Tryptase levels in bronchoalveolar lavage fluid (BALF) may predict the recurrence and chronicity of eosinophilic pneumonia
Source: International Congress 2019 – Immunopathological mechanisms of lung disease
Year: 2019
Clinical significance of hemosiderin-laden macrophages in bronchoalveolar lavage fluid of patients with idiopathic interstitial pneumonias
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013
Cytologicalfeaturesof bronchoalveolar lavage in different variants of exogenous allergic alveolitis
Source: International Congress 2014 – ILDs 5
Year: 2014
Chemokine concentrations in bronchoalveolar lavage (BAL) in asthma and eosinophilic bronchitis
Source: Annual Congress 2004 - Immunology of airway and pulmonary disease
Year: 2004
The effect of MUC5B promoter polymorphism on susceptibility to idiopathic interstitial pneumonias and cell profiles in bronchoalveolar Lavage fluid
Source: International Congress 2015 – IPF pathogenesis
Year: 2015
Th1/Th2 and Tc1/Tc2 profiles in bronchoalveolar lavage and sputum induction in pulmonary sarcoidosis
Source: Eur Respir J 2001; 18: Suppl. 33, 107s
Year: 2001
Biochemical features of bronchoalveolar lavage cells and fluid in different phases of allergic alveolitis
Source: Eur Respir J 2001; 18: Suppl. 33, 409s
Year: 2001
Bronchoalveolar lavage in severe persistent asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 584s
Year: 2002
Bronchoalveolar lavage findings in patients with diffuse interstitial lung disease (DILDs)
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
Th1/Th2/Th17-related cytokines in the bronchoalveolar lavage fluid of patients with sarcoidosis in relation to smoking
Source: Annual Congress 2012 - Diffuse parenchymal lung disease I
Year: 2012
Can IL-4Ralpha and PAR-2 in bronchoalveolar lavage fluid serve as biomarker of fibroproliferative healing in interstitial lung diseases?
Source: International Congress 2015 – New insights into IIPs
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept